Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations (Unaudited)

v3.21.2
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Revenue $ 1,616 $ 1,524 $ 4,720 $ 3,532
Cost of revenue 1,502 1,283 4,059 3,483
Gross profit 114 241 661 49
Operating expenses:        
Research and development 2,695 884 6,804 3,745
Selling, general and administrative 2,911 2,761 9,423 10,476
Total operating expenses 5,606 3,645 16,227 14,221
Loss from operations (5,492) (3,404) (15,566) (14,172)
Gain on forgiveness of Paycheck Protection Program loan 0 0 1,358 0
Modification of warrants 0 0 (373) (1,838)
Interest expense, net (255) (235) (734) (668)
Other expense, net (78) (41) (196) (159)
Net loss from consolidated companies (5,825) (3,680) (15,511) (16,837)
Loss from minority interest in limited liability company (33) (55) (188) (323)
Comprehensive and net loss (5,858) (3,735) (15,699) (17,160)
Series B convertible preferred stock dividends (1,190) (1,053) (3,463) (3,064)
Net loss attributable to common stockholders $ (7,048) $ (4,788) $ (19,162) $ (20,224)
Net loss per share of common stock:        
Basic and diluted (in dollars per share) $ (0.67) $ (2.65) $ (1.93) $ (14.71)
Weighted average shares used in computing net loss per common share:        
Basic and diluted (in shares) 10,591,834 1,807,931 9,916,834 1,374,800